查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生物防御市场2022-2028年：市场预测（按产品（疫苗/生物威胁检测装置））/区域展望/增长潜力/COVID-19影响/市场份额
市场调查报告书
商品编码
1071370

全球生物防御市场2022-2028年：市场预测（按产品（疫苗/生物威胁检测装置））/区域展望/增长潜力/COVID-19影响/市场份额

Biodefense Market Size By Product (Vaccines, Biothreat Detection Devices), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022- 2028
出版日期: | 出版商: Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

生物防御市场将进入 2028 年，随着政府为开发针对突变的有效疫苗以及针对生物威胁的检测设备的治疗策略的推动力度不断加大，预计未来将显着增长。

按产品划分，疫苗行业预计在 2021 年将超过 100 亿美元，并在预测期内实现强劲增长。更多地关注开发新疫苗技术的研究活动，包括诱导快速保护免受病原体攻击的载体技术，预计将推动该行业的增长。

本报告调查全球生物防御市场，定义和概述市场，分析新型冠状病毒感染 (COVID-19) 和其他市场影响因素、市场规模的变化和预测以及各种类型。按类别汇总细分/地区/主要国家、竞争环境、主要公司概况等。

目录

第一章调查方法

第2章执行摘要

第三章生物防御产业的思考

  • 行业分类
  • 产业情况
  • 行业影响因素
    • 生长因子
    • 潜在风险和挑战
  • 增长潜力分析
  • COVID-19：影响分析
  • 波特分析
  • 竞争形势
  • PESTEL 分析

第 4 章生物防御市场：按产品

  • 主要趋势
  • 疫苗
    • 炭疽病
    • 天花
    • 肉毒桿菌中毒
    • 其他
  • 生物威胁检测装置
    • 采样器
    • 探测器/触发装置
    • 标识符
    • 检测/试剂

第 5 章生物防御市场：按地区

  • 主要趋势
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第 6 章公司简介

  • 策略仪表板
  • Alexeter Technologies, LLC
  • Altimmune
  • ANP Technologies
  • Bavarian Nordic
  • BioFire Defense(bioM?rieux SA)
  • Biosearch Technologies
  • Bruker Detection
  • Electronic Sensor Technology Inc.
  • Elusys Therapeutics
  • Emergent BioSolutions
  • Ichor Medical Systems, Inc.
  • Nanologix
  • New Horizon Diagnostic Corp.
  • PositiveID Corporation
  • SIGA Technologies
  • Smiths Detection Group Ltd.
  • Synexis Systems
Product Code: 714

The biodefense market is anticipated to grow substantially by 2028 on account of increasing government initiatives for promoting treatment strategies to develop effective vaccines to combat mutated vaccines as well as detection devices against biothreats. Biodefense refers to measures taken against bioterrorism, which involves the deliberate release of organisms and fatal viruses.

In recent years, governments across the globe have taken various initiatives to instill biodefense mechanisms against bioterrorism. Biothreats not only harm human health but also human resources, which impacts the economic growth of a country. Notably, the COVID-19 pandemic has prompted innovations in the development of vaccinations and biothreat detection devices.

To that effect, in October 2021, the World Health Organization (WHO) called for a change in diagnostics globally to fill the biodefense gap created between LICs (low-income countries) and developed nations, following the launch of the Test-to-Treat initiative by U.S. President Biden, which offers free treatment and testing kits to all American citizens who test positive. As a result, supportive government initiatives for formulating innovative biodefense solutions have been beneficial for biodefense industry growth.

Furthermore, key players in the sector have been investing in consistent improvement and technological advancements in biodefense mechanisms, thereby fostering biodefense market outlook. To cite an instance, in March 2022, Bavarian Nordic, a major biotechnology firm, inked a license & supply deal with Nuance Pharma, a China-based pharmaceutical company. The agreement was undertaken to facilitate the development as well as commercialization of MVA-BN RSV, Bavarian Nordic's vaccine candidate that targets respiratory syncytial virus (RSV) in older adults.

In another instance, in October 2021, Smiths Detection Group Ltd., a leading enterprise in threat detection and security screening tech, announced that its air sampler BioFlash Biological Identifier device is capable of detecting SARS-CoV-2 variants. The air sampler was successfully utilized by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) as well as many universities to curb the spread of COVID-19.

The biodefense market has been segmented based on product and region. Based on product, the market has been further classified into biothreat detection devices and vaccines. The vaccines product segment was valued at more than USD 10 billion in 2021 and is projected to showcase strong growth through the review timeline. Increased emphasis of research activities on the development of new vaccine technologies, including vector technology, to induce rapid protection against pathogen attacks is slated to fuel segmental growth.

In the regional landscape, the Latin America biodefense market is estimated to depict a growth rate of about 8.9% CAGR over 2022-2028. Favorable government initiatives to strengthen biosecurity and growing investments in biodefense products across LATAM are foreseen to promote regional industry growth in the forthcoming years.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Biodefense industry 360 degree synopsis, 2017 - 2028
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Regional trends

Chapter 3 Biodefense Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Technological advancements in biotechnology sector in North America and Europe
      • 3.3.1.2 Favorable government initiatives in Asia Pacific and Latin America
      • 3.3.1.3 Growing investments by government in R&D in North America & Europe
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Low R&D funding by government in underdeveloped regions
  • 3.4 Growth potential analysis
    • 3.4.1 By product
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Biodefense Market, By Product

  • 4.1 Key segment trends
  • 4.2 Vaccines
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.2.2 Anthrax
      • 4.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.2.3 Smallpox
      • 4.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.2.4 Botulism
      • 4.2.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.2.5 Others
      • 4.2.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.3 Biothreat detection devices
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.3.2 Samplers
      • 4.3.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.3.3 Detectors/triggering devices
      • 4.3.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.3.4 Identifiers
      • 4.3.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.3.5 Assays and reagents
      • 4.3.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 5 Biodefense Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 Market size, by country, 2017 - 2028 (USD Million)
    • 5.2.2 Market size, by product, 2017 - 2028 (USD Million)
      • 5.2.2.1 Market size, by vaccines, 2017 - 2028 (USD Million)
      • 5.2.2.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.2.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.2.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.2.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.2.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
  • 5.3 Europe
    • 5.3.1 Market size, by country, 2017 - 2028 (USD Million)
    • 5.3.2 Market size, by Product, 2017 - 2028 (USD Million)
        • 5.3.2.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.3.2.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.3.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.3.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.3.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.3.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.3.5 France
      • 5.3.5.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.3.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.3.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.3.6 Spain
      • 5.3.6.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.3.6.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.3.6.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Market size, by country, 2017 - 2028 (USD Million)
    • 5.4.2 Market size, by product, 2017 - 2028 (USD Million)
        • 5.4.2.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.4.2.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.4.3 Japan
      • 5.4.3.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.4.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.4.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.4.4 China
      • 5.4.4.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.4.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.4.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.4.5 India
      • 5.4.5.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.4.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.4.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Market size, by country, 2017 - 2028 (USD Million)
    • 5.5.2 Market size, by product, 2017 - 2028 (USD Million)
        • 5.5.2.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.5.2.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.5.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.5.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.5.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.5.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.5.5 Argentina
      • 5.5.5.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.5.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.5.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
  • 5.6 MEA
    • 5.6.1 Market size, by country, 2017 - 2028 (USD Million)
    • 5.6.2 Market size, by product, 2017 - 2028 (USD Million)
        • 5.6.2.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.6.2.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.6.3 South Africa
      • 5.6.3.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.6.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.6.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.6.4 Saudi Arabia
      • 5.6.4.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.6.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.6.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
    • 5.6.5 UAE
      • 5.6.5.1 Market size, by product, 2017 - 2028 (USD Million)
        • 5.6.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
        • 5.6.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

Chapter 6 Company Profiles

  • 6.1 Strategy dashboard, 2021
  • 6.2 Alexeter Technologies, LLC
    • 6.2.1 Business overview
    • 6.2.2 Financial data
    • 6.2.3 Product landscape
    • 6.2.4 Strategic outlook
    • 6.2.5 SWOT analysis
  • 6.3 Altimmune
    • 6.3.1 Business overview
    • 6.3.2 Financial data
    • 6.3.3 Product landscape
    • 6.3.4 Strategic outlook
    • 6.3.5 SWOT analysis
  • 6.4 ANP Technologies
    • 6.4.1 Business overview
    • 6.4.2 Financial data
    • 6.4.3 Product landscape
    • 6.4.4 Strategic outlook
    • 6.4.5 SWOT analysis
  • 6.5 Bavarian Nordic
    • 6.5.1 Business overview
    • 6.5.2 Financial data
    • 6.5.3 Product landscape
    • 6.5.4 Strategic outlook
    • 6.5.5 SWOT analysis
  • 6.6 BioFire Defense (bioMérieux SA)
    • 6.6.1 Business overview
    • 6.6.2 Financial data
    • 6.6.3 Product landscape
    • 6.6.4 Strategic outlook
    • 6.6.5 SWOT analysis
  • 6.7 Biosearch Technologies
    • 6.7.1 Business overview
    • 6.7.2 Financial data
    • 6.7.3 Product landscape
    • 6.7.4 Strategic outlook
    • 6.7.5 SWOT analysis
  • 6.8 Bruker Detection
    • 6.8.1 Business overview
    • 6.8.2 Financial data
    • 6.8.3 Product landscape
    • 6.8.4 Strategic outlook
    • 6.8.5 SWOT analysis
  • 6.9 Electronic Sensor Technology Inc.
    • 6.9.1 Business overview
    • 6.9.2 Financial data
    • 6.9.3 Product landscape
    • 6.9.4 Strategic outlook
    • 6.9.5 SWOT analysis
  • 6.10 Elusys Therapeutics
    • 6.10.1 Business overview
    • 6.10.2 Financial data
    • 6.10.3 Product landscape
    • 6.10.4 Strategic outlook
    • 6.10.5 SWOT analysis
  • 6.11 Emergent BioSolutions
    • 6.11.1 Business overview
    • 6.11.2 Financial data
    • 6.11.3 Product landscape
    • 6.11.4 Strategic outlook
    • 6.11.5 SWOT analysis
  • 6.12 Ichor Medical Systems, Inc.
    • 6.12.1 Business overview
    • 6.12.2 Financial data
    • 6.12.3 Product landscape
    • 6.12.4 Strategic outlook
    • 6.12.5 SWOT analysis
  • 6.13 Nanologix
    • 6.13.1 Business overview
    • 6.13.2 Financial data
    • 6.13.3 Product landscape
    • 6.13.4 Strategic outlook
    • 6.13.5 SWOT analysis
  • 6.14 New Horizon Diagnostic Corp.
    • 6.14.1 Business overview
    • 6.14.2 Financial data
    • 6.14.3 Product landscape
    • 6.14.4 Strategic outlook
    • 6.14.5 SWOT analysis
  • 6.15 PositiveID Corporation
    • 6.15.1 Business overview
    • 6.15.2 Financial data
    • 6.15.3 Product landscape
    • 6.15.4 Strategic outlook
    • 6.15.5 SWOT analysis
  • 6.16 SIGA Technologies
    • 6.16.1 Business overview
    • 6.16.2 Financial data
    • 6.16.3 Product landscape
    • 6.16.4 Strategic outlook
    • 6.16.5 SWOT analysis
  • 6.17 Smiths Detection Group Ltd.
    • 6.17.1 Business overview
    • 6.17.2 Financial data
    • 6.17.3 Product landscape
    • 6.17.4 Strategic outlook
    • 6.17.5 SWOT analysis
  • 6.18 Synexis Systems
    • 6.18.1 Business overview
    • 6.18.2 Financial data
    • 6.18.3 Product landscape
    • 6.18.4 Strategic outlook
    • 6.18.5 SWOT analysis

Data Tables

  • TABLE 1 Biodefense industry 360 degree synopsis, 2017-2028
  • TABLE 2 Global biodefense market, 2017-2021 (USD Million)
  • TABLE 3 Global biodefense market, 2022-2028 (USD Million)
  • TABLE 4 Global biodefense market, by product, 2017-2021 (USD Million)
  • TABLE 5 Global biodefense market, by product, 2022-2028 (USD Million)
  • TABLE 6 Global biodefense market, by region, 2017-2021 (USD Million)
  • TABLE 7 Global biodefense market, by region, 2022-2028 (USD Million)
  • TABLE 8 Industry impact forces
  • TABLE 9 Vaccines market size, by region, 2017-2021 (USD Million)
  • TABLE 10 Vaccines market size, by region, 2022-2028 (USD Million)
  • TABLE 11 Anthrax market size, by region, 2017-2021 (USD Million)
  • TABLE 12 Anthrax market size, by region, 2022-2028 (USD Million)
  • TABLE 13 Smallpox market size, by region, 2017-2021 (USD Million)
  • TABLE 14 Smallpox market size, by region, 2022-2028 (USD Million)
  • TABLE 15 Botulism market size, by region, 2017-2021 (USD Million)
  • TABLE 16 Botulism market size, by region, 2022-2028 (USD Million)
  • TABLE 17 Others market size, by region, 2017-2021 (USD Million)
  • TABLE 18 Others market size, by region, 2022-2028 (USD Million)
  • TABLE 19 Biothreat detection devices market size, by region, 2017-2021 (USD Million)
  • TABLE 20 Biothreat detection devices market size, by region, 2022-2028 (USD Million)
  • TABLE 21 Samplers market size, by region, 2017-2021 (USD Million)
  • TABLE 22 Samplers market size, by region, 2022-2028 (USD Million)
  • TABLE 23 Detectors/triggering market size, by region, 2017-2021 (USD Million)
  • TABLE 24 Detectors/triggering detection devices market size, by region, 2022-2028 (USD Million)
  • TABLE 25 Identifiers market size, by region, 2017-2021 (USD Million)
  • TABLE 26 Identifiers market size, by region, 2022-2028 (USD Million)
  • TABLE 27 Assays and reagents market size, by region, 2017-2021 (USD Million)
  • TABLE 28 Assays and reagents market size, by region, 2022-2028 (USD Million)
  • TABLE 29 North America biodefense market size, by country, 2017-2021 (USD Million)
  • TABLE 30 North America biodefense market size, by country, 2022-2028 (USD Million)
  • TABLE 31 North America biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 32 North America biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 33 North America biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 34 North America biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 35 North America biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 36 North America biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 37 U.S. biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 38 U.S. biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 39 U.S. biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 40 U.S. biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 41 U.S. biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 42 U.S. biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 43 Canada biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 44 Canada biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 45 Canada biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 46 Canada biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 47 Canada biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 48 Canada biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 49 Europe biodefense market size, by country, 2017-2021 (USD Million)
  • TABLE 50 Europe biodefense market size, by country, 2022-2028 (USD Million)
  • TABLE 51 Europe biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 52 Europe biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 53 Europe biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 54 Europe biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 55 Europe biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 56 Europe biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 57 Germany biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 58 Germany biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 59 Germany biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 60 Germany biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 61 Germany biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 62 Germany biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 63 UK biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 64 UK biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 65 UK biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 66 UK biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 67 UK biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 68 UK biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 69 France biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 70 France biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 71 France biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 72 France biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 73 France biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 74 France biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 75 Spain biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 76 Spain biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 77 Spain biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 78 Spain biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 79 Spain biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 80 Spain biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 81 Asia Pacific biodefense market size, by country, 2017-2021 (USD Million)
  • TABLE 82 Asia Pacific biodefense market size, by country, 2022-2028 (USD Million)
  • TABLE 83 Asia Pacific biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 84 Asia Pacific biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 85 Asia Pacific biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 86 Asia Pacific biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 87 Asia Pacific biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 88 Asia Pacific biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 89 Japan biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 90 Japan biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 91 Japan biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 92 Japan biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 93 Japan biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 94 Japan biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 95 China biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 96 China biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 97 China biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 98 China biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 99 China biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 100 China biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 101 India biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 102 India biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 103 India biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 104 India biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 105 India biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 106 India biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 107 Australia biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 108 Australia biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 109 Australia biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 110 Australia biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 111 Australia biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 112 Australia biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 113 Latin America biodefense market size, by country, 2017-2021 (USD Million)
  • TABLE 114 Latin America biodefense market size, by country, 2022-2028 (USD Million)
  • TABLE 115 Latin America biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 116 Latin America biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 117 Latin America biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 118 Latin America biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 119 Latin America biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 120 Latin America biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 121 Brazil biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 122 Brazil biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 123 Brazil biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 124 Brazil biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 125 Brazil biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 126 Brazil biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 127 Mexico biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 128 Mexico biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 129 Mexico biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 130 Mexico biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 131 Mexico biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 132 Mexico biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 133 Argentina biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 134 Argentina biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 135 Argentina biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 136 Argentina biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 137 Argentina biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 138 Argentina biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 139 MEA biodefense market size, by country, 2017-2021 (USD Million)
  • TABLE 140 MEA biodefense market size, by country, 2022-2028 (USD Million)
  • TABLE 141 MEA biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 142 MEA biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 143 MEA biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 144 MEA biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 145 MEA biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 146 MEA biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 147 South Africa biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 148 South Africa biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 149 South Africa biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 150 South Africa biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 151 South Africa biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 152 South Africa biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 153 Saudi Arabia biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 154 Saudi Arabia biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 155 Saudi Arabia biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 156 Saudi Arabia biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 157 Saudi Arabia biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 158 Saudi Arabia biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)
  • TABLE 159 UAE biodefense market size, by product, 2017-2021 (USD Million)
  • TABLE 160 UAE biodefense market size, by product, 2022-2028 (USD Million)
  • TABLE 161 UAE biodefense market size, by vaccines, 2017-2021 (USD Million)
  • TABLE 162 UAE biodefense market size, by vaccines, 2022-2028 (USD Million)
  • TABLE 163 UAE biodefense market size, by biothreat detection devices, 2017-2021 (USD Million)
  • TABLE 164 UAE biodefense market size, by biothreat detection devices, 2022-2028 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global biodefense market, 2017 - 2028 (USD Million)
  • FIG. 3 Growth potential analysis, by product
  • FIG. 4 Porter's analysis
  • FIG. 5 PESTEL analysis
  • FIG. 6 Key segment trends, by product
  • FIG. 7 Key regional trends
  • FIG. 8 Strategy dashboard, 2021